Closure of the left atrial appendage using percutaneous transcatheter occlusion devices

Carola Gianni; Alisara Anannab; Anu Sahore Salwan; Domenico G Della Rocca; Andrea Natale; Rodney P Horton

doi:10.1111/jce.14471

Closure of the left atrial appendage using percutaneous transcatheter occlusion devices

J Cardiovasc Electrophysiol. 2020 Aug;31(8):2179-2186. doi: 10.1111/jce.14471. Epub 2020 Apr 29.

Authors

Carola Gianni¹, Alisara Anannab^{1

2}, Anu Sahore Salwan¹, Domenico G Della Rocca¹, Andrea Natale^{1

3

4

5}, Rodney P Horton^{1

6}

Affiliations

¹ Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.
² Electrophysiology Unit, Department of Cardiovascular Interventions, Central Chest Institute of Thailand, Nonthaburi, Thailand.
³ HCA National Medical Director of Cardiac Electrophysiology, USA.
⁴ Scripps Clinic, La Jolla, California.
⁵ MetroHealth Medical Center, Cleveland, Ohio.
⁶ Department of Biomedical Engineering, Austin, Texas.

PMID: 32249473
DOI: 10.1111/jce.14471

Abstract

Closure of the left atrial appendage (LAA) using percutaneous transcatheter occlusion devices is used for stroke prevention as an alternative for patients with a high risk and contraindications for long-term oral anticoagulation use. In this manuscript, we will discuss the practical aspects of four among the available devices that provide percutaneous intravascular closure of the LAA: Watchman, Amulet, WaveCrest, and LAmbre.

Keywords: left atrial appendage occlusion.

Publication types

Review

MeSH terms

Administration, Oral
Atrial Appendage* / diagnostic imaging
Atrial Appendage* / surgery
Atrial Fibrillation* / diagnostic imaging
Atrial Fibrillation* / surgery
Cardiac Catheterization / adverse effects
Humans
Stroke* / etiology
Stroke* / prevention & control
Treatment Outcome